Asparaginsäurederivate

European patent · EP2886531 · In force

Register entry

Publication number
EP2886531
Application number
EP14003926
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 21, 2014
Published
Jun 24, 2015
Granted
Jun 8, 2016
Protection ends at the latest
Nov 20, 2034
Next annual fee due
Nov 30, 2026
IPC classes
C07C 271/22 (2006.01)
C07C 229/24 (2006.01)
C07K 1/06 (2006.01)
Priority
EP 13005920 19.12.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Jun 8, 2016

    Granted

    Published in Swissreg on 08.06.2016

Parties

Holder

Merck Patent GmbH

Frankfurter Strasse 250, 64293 Darmstadt, DE

Inventor

Behrendt, Raymond

78224 Singen, DE

Willibald, Julian

81543 Muenchen, DE

White, Peter

Southwell, NG25 0HQ, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.